LOGICBIO THERAPEUTICS INC's ticker is LOGC and the CUSIP is 54142F102. A total of 38 filers reported holding LOGICBIO THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $124,000 | -70.6% | 182,630 | 0.0% | 0.04% | -67.7% |
| Q4 2021 | $422,000 | -49.5% | 182,630 | 0.0% | 0.13% | -52.4% |
| Q3 2021 | $836,000 | +3.1% | 182,630 | 0.0% | 0.27% | +32.2% |
| Q2 2021 | $811,000 | -10.5% | 182,630 | +45.1% | 0.20% | -6.5% |
| Q4 2019 | $906,000 | -31.6% | 125,836 | +2.7% | 0.22% | -49.4% |
| Q3 2019 | $1,325,000 | -23.1% | 122,536 | -7.5% | 0.43% | +2.9% |
| Q2 2019 | $1,723,000 | +9.7% | 132,540 | -16.6% | 0.42% | -2.1% |
| Q1 2019 | $1,571,000 | -5.0% | 158,958 | 0.0% | 0.42% | -29.6% |
| Q4 2018 | $1,653,000 | – | 158,958 | – | 0.60% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Board of Trustees of The Leland Stanford Junior University | 909,244 | $8,984,000 | 1.25% |
| Orbimed Advisors | 6,466,783 | $63,892,000 | 0.99% |
| Lion Point Capital, LP | 500,000 | $4,940,000 | 0.45% |
| Sio Capital Management, LLC | 158,958 | $1,571,000 | 0.42% |
| SPHERA FUNDS MANAGEMENT LTD. | 417,625 | $4,126,000 | 0.38% |
| Redmile Group, LLC | 909,787 | $8,989,000 | 0.26% |
| SAMLYN CAPITAL, LLC | 634,283 | $6,266,000 | 0.15% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 910,000 | $8,991,000 | 0.02% |
| FRANKLIN RESOURCES INC | 700,000 | $6,916,000 | 0.00% |
| UBS Group AG | 47 | $0 | 0.00% |